ORYX attended the 2018 Society for Neuro-Oncology Annual Meeting, taking place in New Orleans, USA on November 15-18, 2018.

The abstract "High rate of objective anti-tumor response in 9 patients with glioblastoma after viro-immunotherapy with oncolytic parvovirus H-1 in combination with bevacicumab and PD-1 checkpoint blockade" was presented by Dr. Karsten Geletneky, Department of Neurosurgery, Darmstadt Medical Center during the "Concurrent Session 8C: Immunology - Preclinical and Clinical II" on November 18, 2018 from 10:50 - 11:00am CST.